A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Clinical trial NCT06699602 · RECRUITING
Trial details
- NCT number
- NCT06699602
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2028-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.